HOSPITAL OF THE UNIV OF PENNA
1. Target Overview & Investment Thesis
HOSPITAL OF THE UNIV OF PENNA is a 1051-bed large academic medical center in PHILADELPHIA, PA with $3.36B in net patient revenue and a -12.8% operating margin. The hospital serves a payer mix of 23.5% Medicare, 2.3% Medicaid, and 74.3% commercial.
Thesis: Undervalued. Our ML models identify $247.6M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -12.8% to -5.4% (+736bps).
| Net Revenue HCRIS | $3.36B |
| Current EBITDA COMPUTED | $-428.9M |
| Operating Margin COMPUTED | -12.8% |
| Occupancy HCRIS | 75.6% |
| Revenue / Bed COMPUTED | $3.2M |
| Net-to-Gross HCRIS | 17.3% |
| Distress Probability ML | 40.5% |
2. Market Context & Competitive Position
PA has 225 Medicare-certified hospitals with a median operating margin of -4.4%. The target's margin of -12.8% places it below the state median. Among 13 size-comparable peers (526-2102 beds), the median margin is -2.6%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (526-2102), prioritizing same-state peers. 13 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| HOSPITAL OF THE UNIV OF PENNA (Target) | PA | 1051 | $3.36B | -12.8% |
| ST. LUKES HOSPITAL | PA | 633 | $8.94B | 87.9% |
| LEHIGH VALLEY | PA | 1190 | $2.84B | -5.9% |
| THE CHILDRENS HOSPITAL OF PHIL | PA | 667 | $2.70B | -26.8% |
| UPMC - PRESBYTERIAN SHADYSIDE | PA | 1141 | $2.24B | -23.0% |
| MILTON S. HERSHEY MEDICAL CENT | PA | 616 | $2.08B | -2.8% |
| TEMPLE UNIVERSITY HOSPITAL | PA | 761 | $1.99B | 0.8% |
| THOMAS JEFFERSON UNIV. HOSPITA | PA | 868 | $1.93B | -23.1% |
| YORK HOSPITAL | PA | 533 | $1.47B | 9.7% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $247.6M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $70.6M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $67.3M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $66.6M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $40.9M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $2.2M | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-428.9M |
| + RCM Uplift | +$247.6M |
| Pro Forma EBITDA | $-181.3M |
| Current Margin | -12.8% |
| Pro Forma Margin | -5.4% |
| WC Released (1x) | $129.0M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-659.9M | $-353.1M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-659.9M | $-602.7M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-593.9M | $172K | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-593.9M | $-175.2M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-725.9M | $-1.38B | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-725.9M | $-1.75B | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Low | Low net-to-gross ratio | Large contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 13 hospitals with 526-2102 beds
- Same-state prioritization (n=14)
- Comp margins: P25=-19.5% / P50=-2.6% / P75=6.1%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.